Search results for "Diabetic macular edema"

Results appear similar at 2 years for diabetic macular edema drugs

Eyes were assigned to receive 2.0 mg aflibercept, 1.25 mg repackaged (compounded) bevacizumab, or 0.3 mg ranibizumab. Intravitreous injections were administered up to once per month according to a follow-up and retreatment regimen specified by protocol.
https://diabetes.acponline.org/archives/2016/03/11/3.htm
11 Mar 2016